Comparative Effects of Weight Bearing and Non-weight Bearing Exercises in Patients With Total Hip Replacement

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05375565
Collaborator
(none)
22
1
2
10
2.2

Study Details

Study Description

Brief Summary

to compare the effects of weight bearing and non-weight bearing exercises on pain, range of motion and disability in patients with total hip replacement

Condition or Disease Intervention/Treatment Phase
  • Other: weight bearing exercises
  • Other: non weight bearing exercises
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparative Effects of Weight Bearing and Non-weight Bearing Exercises on Pain, Range of Motion and Disability in Patients With Total Hip Replacement
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Jul 31, 2022
Anticipated Study Completion Date :
Jul 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: weight bearing exercises

weight bearing exercises

Other: weight bearing exercises
Standing knee raise 10 rep x 2sets Standing knee bend 10 rep x 2sets Standing hip extension 10 rep x 2sets Shallow squats 5 rep x 2 sets After 4 week gradually restricting the use of assistive device when patient become able to walk and stand for 10 mins then add stair climbing and descending with a step height not higher than 7 inch. The session will be around 45 to 60 minutes on each patient with 2 sessions per week on alternate days to observe the long term effects.

Experimental: non weight bearing exercises

non weight bearing exercises

Other: non weight bearing exercises
Seated knee flexion 10 rep x 2sets Seated knee extension 10 rep x2sets Use of stationary bicycle 10 mins Side lying leg lift 10 rep x2sets Straight leg raise 10 rep x 2sets The session will be around 45 to 60 minutes on each patient with 2 sessions per week on alternate days to observe the long term effects.

Outcome Measures

Primary Outcome Measures

  1. Numeric pain rating scale (NPRS) [6 weeks]

    NPRS is anchored by terms describing pain severity extremes. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable"

  2. Goniometry [6 weeks]

    A goniometer is a device that measures an angle or permits the rotation of an object to a definite position

  3. Hip disability and Osteoarthritis Outcome Score (HOOS) [6 weeks]

    A 40 item questionnaire (hip disability and osteoarthritis outcome score, HOOS) was constructed to assess patient-relevant outcomes in five separate subscales (pain, symptoms, activity of daily living, sport and recreation function and hip related quality of life).

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • unilateral total hip arthroplasty

  • posterolateral approach of hip replacement

  • patients that were willing to participate

  • patients with 2 weeks post-operative history of total hip replacement

Exclusion Criteria:
  • History of any systemic pathology

  • Individual suffering from congenital hip disease.

  • Bilateral total hip arthroplasty

  • Evidence of CNS involvement and any other neurological involvement

  • Any red flag (malignancies or any kind of tumor

  • History of lower extremity fracture.

  • Patient having any local or systemic infection of hip joint

Contacts and Locations

Locations

Site City State Country Postal Code
1 Lahore General hospital Lahore Punjab Pakistan 64000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: hina gul, t-DPT, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05375565
Other Study ID Numbers:
  • REC/Lhr/22/0140 Habiba
First Posted:
May 16, 2022
Last Update Posted:
Jul 15, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University

Study Results

No Results Posted as of Jul 15, 2022